Exchange: NASDAQ·Updated 01:01 PM EDT

GNFT Genfit

$0.0207
$0.0008
(4.02%)
Today
Reported EarningsMay 22
Mkt Cap$446.03M
Vol1.82M

About GNFT

Genfit SA is a biopharmaceutical company involved in drug discovery and development for the early diagnosis, prevention and treatment of cardiometabolic diseases. The company focuses on the discovery and development of drug candidates in areas of high unmet medical needs corresponding to a lack of suitable treatments. It focuses on medicines to market for patients with metabolic, inflammatory, autoimmune and fibrotic diseases that affect the liver. The company was founded by Jean-François Mouney, Florence Séjourné, and Bart Staels in September 1999 and is headquartered in Loos, France.
55

Bullish Sentiment

How do you feel about GNFT?

Advertisement|Remove ads.